The Clinical Spectrum of McCune-Albright Syndrome and Its Management
Authors:
Open Access
- 19 December 2019
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 92 (6) , 347-356
Abstract
McCune-Albright syndrome (MAS) is a rare, mosaic disorder presenting along a broad clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to constitutive Gαs activation and ligand-independent signaling of the Gαs-coupled protein receptor. The phenotype is largely determined by location and extent of tissues in which the GNAS mutation is expressed, as well as the pathophysiologic effects of Gαs activation within these tissues. Patients present clinically with a variable combination of fibrous dysplasia of bone (FD), café-au-lait skin macules, and hyperfunctioning endocrinopathies. In bone, Gαs leads to impaired differentiation of skeletal stem cells and formation of discrete, expansile FD lesions, resulting in fractures, pain, and functional impairment. A systematic approach to diagnosis and management is critically important to optimize outcomes for patients with FD/MAS. There are no medical therapies capable of altering the disease course in FD; however, screening and treatment for endocrinopathies can mitigate some skeletal morbidities. This review summarizes current understanding of MAS pathophysiology, describes the spectrum of clinical features, and includes a detailed discussion of the recommended approach to diagnosis and management.Keywords
This publication has 75 references indexed in Scilit:
- Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndromeInternational Journal of Pediatric Endocrinology, 2012
- McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasiaOrphanet Journal of Rare Diseases, 2012
- Pathophysiology and medical treatment of pain in fibrous dysplasia of boneOrphanet Journal of Rare Diseases, 2012
- The surgical management of fibrous dysplasia of boneOrphanet Journal of Rare Diseases, 2012
- Surgery versus Watchful Waiting in Patients with Craniofacial Fibrous Dysplasia – a Meta-AnalysisPLOS ONE, 2011
- Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst DevelopmentScience Translational Medicine, 2011
- A clinician's guide to X-linked hypophosphatemiaJournal of Bone and Mineral Research, 2011
- Cushing Syndrome in the McCune-Albright SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2010
- Age-Dependent Demise of GNAS-Mutated Skeletal Stem Cells and “Normalization” of Fibrous Dysplasia of BoneJournal of Bone and Mineral Research, 2008
- The Role of Type 1 and Type 2 5′-Deiodinase in the Pathophysiology of the 3,5,3′-Triiodothyronine Toxicosis of McCune-Albright SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008